Neuroendocrine prostate cancer (NEPC)
Clinical trials for Neuroendocrine prostate cancer (NEPC) explained in plain language.
Never miss a new study
Get alerted when new Neuroendocrine prostate cancer (NEPC) trials appear
Sign up with your email to follow new studies for Neuroendocrine prostate cancer (NEPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called ML261 for people with advanced small cell lung cancer or certain neuroendocrine cancers that have not responded to standard treatments. ML261 is made from a patient's own immune cells, which are modified in a lab to better recog…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase 1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis study tests a new drug, peluntamig (PT217), in people with advanced neuroendocrine cancers like small cell lung cancer. The drug is designed to attach to two proteins (DLL3 and CD47) found on cancer cells, potentially helping the immune system attack them. The trial will fir…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase 1/2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC